A step closer to getting the vaccine in the fight against COVID-19: Read on for details
New Delhi: The Drugs Controller General of India (DCGI) has given nod to Serum Institute of India (SII) for conducting Phase 2 and 3 human clinical trials of the Oxford University developed COVID-19 vaccine candidate in India. Government officials said that the approval was granted...











































